<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00365638</url>
  </required_header>
  <id_info>
    <org_study_id>636/04</org_study_id>
    <nct_id>NCT00365638</nct_id>
  </id_info>
  <brief_title>Simvastatin Therapy in Women With Polycystic Ovary Syndrome.</brief_title>
  <official_title>Effects of Simvastatin on Clinical, Endocrine, Metabolic and Biochemical Parameters of Women With Polycystic Ovary Syndrome: Prospective, Randomized Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poznan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Poznan University of Medical Sciences</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether statins (simvastatin) improve clinical
      (excessive hair, skin problems), endocrine (androgens) and metabolic (lipids, markers of
      systemic inflammation) in women with polycystic ovary syndrome (PCOS).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2004</start_date>
  <completion_date>February 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum testosterone</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum lutropin</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum follitropin</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum lipids</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum DHEA-S</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum SHBG</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum insulin</measure>
  </secondary_outcome>
  <condition>Polycystic Ovary Syndrome</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>simvastatin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PCO - ESHRE/ASRM criteria: oligomenorrhea (&lt;8 spontaneous menses per year) and
             hyperandrogenism (hirsutism or acne) or hyperandrogenemia (testosterone &gt;70ng/dl)

          -  Normal prolactin, TSH, 17-OH progesterone

          -  No evidence of androgen producing malignancy, Cushingâ€™s syndrome or acromegaly

          -  Age 18-40

          -  Reliable use of birth control pill for at least 3 months and no plans of pregnancy

        Exclusion Criteria:

          -  Elevated creatinine kinase above 2 times upper limit of normal or liver enzymes
             (transaminases) above 2 times of upper limit of normal

          -  Use of any of the following medications: cyclosporine, fibrates, niacin, antifungal
             agents, macrolide antibiotics.

          -  Use of oral contraceptives and other steroid hormones 3 months prior to the study

          -  Contraindications to oral contraceptives
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leszek Pawelczyk, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Poznan University of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antoni J Duleba, MD</last_name>
    <role>Study Director</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics</name>
      <address>
        <city>Poznan</city>
        <zip>60-184</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <results_reference>
    <citation>Duleba AJ, Banaszewska B, Spaczynski RZ, Pawelczyk L. Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial. Fertil Steril. 2006 Apr;85(4):996-1001. Epub 2006 Mar 9.</citation>
    <PMID>16580386</PMID>
  </results_reference>
  <verification_date>September 2004</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2006</study_first_submitted>
  <study_first_submitted_qc>August 15, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2006</study_first_posted>
  <last_update_submitted>August 15, 2006</last_update_submitted>
  <last_update_submitted_qc>August 15, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2006</last_update_posted>
  <keyword>PCOS</keyword>
  <keyword>statin</keyword>
  <keyword>testosterone</keyword>
  <keyword>lipids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

